CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Open-market buy 10% owner bought 29,400 shares at $10.56 ($310,391)
- 4 Open-market buy 10% owner bought 50,000 shares at $12.82 ($641,000)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 9,000 shares at $11.59 ($104,310)
- 4 Open-market buy 10% owner bought 50,600 shares at $9.65 ($488,290)
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations · Regulation FD disclosure
- 10-K Report Annual Report
- 4 Option exercise CEO of ImprimisRx acquired 5,000 shares (option exercise)
- 4 Option exercise CEO of ImprimisRx acquired 30,000 shares (option exercise)
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 45,000 shares (option exercise)
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 150,000 shares (option exercise)
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 15,400 shares (option exercise)
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 7,400 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 44 · 872 filings